The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held
virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in …

Breast cancer is the most common cancer worldwide. The occurrence of breast cancer is
associated with many risk factors, including genetic and hereditary predisposition. Breast …

Simple Summary Currently, it is unclear which kind of axillary staging surgery breast cancer
patients with lymph node metastasis should receive after neoadjuvant chemotherapy. For …

Importance Prospective trials have demonstrated sentinel lymph node (SLN) false-negative
rates of less than 10% when 3 or more SLNs are retrieved in patients with clinically node …

Simple Summary The 5-year survival rate for patients with breast cancer, in whom disease
has spread to local lymph nodes, is 85%. However, many live with the complications of …

Importance The increasing use of neoadjuvant systemic therapy (NST) has led to substantial
pathological complete response rates in patients with initially node-positive, early breast …

Aim We developed tailored axillary surgery (TAS) to reduce the axillary tumor volume in
patients with clinically node-positive breast cancer to the point where radiotherapy can …

The increased use of neoadjuvant chemotherapy (NACT) has changed the approach to
breast surgery. NACT allows de-escalation of surgery by both increasing breast …

Simple Summary Axillary status is crucial for determining the correct local and systemic
treatment. The possibility of de-escalating axillary surgery in patients with breast cancer …

Purpose Neoadjuvant chemotherapy (NACT) is increasingly adopted in the therapy of breast
cancer (BC) patients with positive axillary nodes (cN+), but the reliability and feasibility of …